Glioblastomas are the most common and most aggressive brain tumors. Their survival rate has barely increased over the last 50 years, indicating an urgent need to develop new therapeutic strategies. In a paper published this ...
Apr 12, 2021
0
12
Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muñoz, have described the mechanisms, unknown to date, involved in maintaining embryonic stem cells in the best ...
Mar 25, 2021
0
4
Aging is a common factor in many diseases. So, what if it were possible to treat them by acting on the causes of aging or, more specifically, by acting on the shortening of telomeres, the structures that protect chromosomes? ...
Mar 15, 2021
0
63
The Telomeres and Telomerase Group led by Maria A. Blasco at the Spanish National Cancer Research Centre (CNIO) continues to make progress in unraveling the role that telomeres—the ends of chromosomes that are responsible ...
Mar 10, 2021
0
4
Patients with severe COVID-19 disease have significantly shorter telomeres, according to a study conducted by researchers at the Spanish National Cancer Research Centre (CNIO) in collaboration with the COVID-IFEMA Field Hospital, ...
Jan 11, 2021
0
25
Despite the success of immunotherapy in the treatment of cancers such as lung or melanoma, it is still not effective in breast cancers for being 'cold', with low infiltration of immune cells. Tumors use strategies to evade ...
Dec 10, 2020
0
8
It has recently been described that infection by some enteroviruses—a genus of viruses that commonly cause diseases of varying severity—could potentially trigger diabetes, although its direct effect 'in vivo' as well ...
Oct 20, 2020
0
68
The sophisticated human immune system has evolved to become an effective protection system against a great number of diseases, including cancer. The immune system recognizes and destroys cancer cells using a monitoring process ...
Oct 19, 2020
0
37
The CRISPR/Cas9 gene-editing tool is one of the most promising approaches to advancing treatments of genetic diseases—including cancer—an area of research where progress is constantly being made. Now, the Molecular Cytogenetics ...
Oct 8, 2020
0
137
Capecitabine is a chemotherapy drug used for breast and colorectal cancer. It can extend survival rate by nearly 10%. However, recent studies revealed that almost 50% of patients develop palmar-plantar erythrodysesthesia, ...
Sep 21, 2020
0
2
